Unitedhealth Group Inc (NYSE:UNH) shares traded -0.19% lower at $295.00 on Wall Street last session.
UNH stock price is now -33.92% away from the 50-day moving average and -43.97% away from the 200-day moving average. The market capitalization of the company currently stands at $267.61B.
With the price target maintained at $270, HSBC Securities recently Downgraded its rating from Hold to Reduce for Unitedhealth Group Inc (NYSE: UNH). On May 19, 2025, TD Cowen Downgraded its previous ‘Buy’ rating to ‘Hold’ on the stock keeping its target price maintained at $308, while ‘Raymond James’ rates the stock as ‘Mkt Perform’
In other news, REX JOHN F, President & CFO bought 17,175 shares of the company’s stock on May 16 ’25. The stock was bought for $4,999,919 at an average price of $291.12. Upon completion of the transaction, the President & CFO now directly owns 203,796 shares in the company, valued at $60.12 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 16 ’25, CEO, UHG HEMSLEY STEPHEN J bought 86,700 shares of the business’s stock. A total of $25,019,019 was incurred on buying the stock at an average price of $288.57. This leaves the insider owning 679,493 shares of the company worth $200.45 million. A total of 0.24% of the company’s stock is owned by insiders.
During the past 12 months, Unitedhealth Group Inc has had a low of $248.88 and a high of $630.73.
The net profit margin was 5.39% and return on equity was 24.33% for UNH. The company reported revenue of $109.58 billion for the quarter, compared to $99.8 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 9.8 percent.
